These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11337133)

  • 41. Inverse relationship between fenfluramine-induced prolactin release and blood pressure in humans.
    Muldoon MF; Sved AF; Flory JD; Perel JM; Matthews KA; Manuck SB
    Hypertension; 1998 Dec; 32(6):972-5. PubMed ID: 9856959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low prolactin response to fenfluramine in impulsive aggression.
    New AS; Trestman RF; Mitropoulou V; Goodman M; Koenigsberg HH; Silverman J; Siever LJ
    J Psychiatr Res; 2004; 38(3):223-30. PubMed ID: 15003426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration.
    O'Keane V; O'Hanlon M; Webb M; Dinan T
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):289-92. PubMed ID: 1879060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN
    Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women.
    Lasco A; Cannavò S; Gaudio A; Morabito N; Basile G; Nicita-Mauro V; Frisina N
    Eur J Endocrinol; 2002 Oct; 147(4):461-5. PubMed ID: 12370106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D-fenfluramine challenge in posttraumatic stress disorder.
    Davis LL; Clark DM; Kramer GL; Moeller FG; Petty F
    Biol Psychiatry; 1999 Apr; 45(7):928-30. PubMed ID: 10202582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gender-related differences in functional assessment of serotonergic system in healthy young subjects].
    Silva H; Nieto R; Montes C; Paredes A; Rentería P; Ramírez A; Jérez S
    Actas Esp Psiquiatr; 2008; 36(4):218-22. PubMed ID: 18615275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
    Giambalvo CT; Price LH
    Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.
    Lanctôt KL; Herrmann N; Eryavec G; van Reekum R; Reed K; Naranjo CA
    Neuropsychopharmacology; 2002 Oct; 27(4):646-54. PubMed ID: 12377401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone replacement therapy for cognitive function in postmenopausal women.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women.
    Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I
    Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S
    Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolactin response to fenfluramine in abstinent, alcohol-dependent patients.
    Porter RJ; Sellman D; Joyce PR; Davies J; Frampton C
    Addict Biol; 2008 Sep; 13(3-4):380-5. PubMed ID: 18279498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
    Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.
    Kalleinen N; Polo-Kantola P; Irjala K; Porkka-Heiskanen T; Vahlberg T; Virkki A; Polo O
    J Clin Endocrinol Metab; 2008 May; 93(5):1655-61. PubMed ID: 18319308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.